Literature DB >> 9114398

Molecular evolution of Vibrio cholerae O1 strains isolated in Lima, Peru, from 1991 to 1995.

A Dalsgaard1, M N Skov, O Serichantalergs, P Echeverria, R Meza, D N Taylor.   

Abstract

Following the emergence of cholera in Lima, Peru, in 1991, isolates of Vibrio cholerae O1 biotype El Tor recovered from patients in various parts of Lima were selected and characterized. Ribotyping and pulsed-field gel electrophoresis (PFGE) revealed four BglI ribotypes and eight NotI PFGE types among 50 V. cholerae O1 strains recovered from patients with cholera in Lima from 1991 to 1995, with certain genotypes appearing to cluster geographically. While differences in ribotype and PFGE type patterns suggest that genetic changes are occurring in the strain responsible for the Latin American cholera epidemic, more frequently than previously reported, 40 (80%) O1 strains showed an identical ribotype pattern and 41 (82%) strains showed closely related PFGE types, types 1, 2, or 3, that differed by less than three restriction fragments. All strains were susceptible to nine antibacterial agents studied. In 1991, more than 95% of the clinical V. cholerae O1 strains were serotype Inaba, whereas from 1992, serotype Ogawa began to predominate, with more than 90% of the isolates being of the Ogawa serotype in 1995. The small differences in genotypes of V. cholerae O1 is remarkable because cholera is highly seasonal in coastal areas of Peru and support the hypothesis that the epidemic strain reemerges from an environmental source. However, the relative high rate of genetic changes within V. cholerae O1 as shown by ribotyping and PFGE should be taken into consideration when typing patterns of V. cholerae O1 associated with cholera in Latin America are evaluated.

Entities:  

Mesh:

Year:  1997        PMID: 9114398      PMCID: PMC232720          DOI: 10.1128/jcm.35.5.1151-1156.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Comparison of Pulsed-Field Gel Electrophoresis, Ribotyping, and Plasmid Profiling for Typing of Vibrio anguillarum Serovar O1.

Authors:  M N Skov; K Pedersen; J L Larsen
Journal:  Appl Environ Microbiol       Date:  1995-04       Impact factor: 4.792

Review 2.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

3.  Rapid isolation of high molecular weight plant DNA.

Authors:  M G Murray; W F Thompson
Journal:  Nucleic Acids Res       Date:  1980-10-10       Impact factor: 16.971

4.  Pulsed field gel electrophoresis as a new epidemiological tool for monitoring methicillin-resistant Staphylococcus aureus in an intensive care unit.

Authors:  G Prévost; B Pottecher; M Dahlet; M Bientz; J M Mantz; Y Piémont
Journal:  J Hosp Infect       Date:  1991-04       Impact factor: 3.926

5.  Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12.

Authors:  G D Pearson; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Molecular epidemiology of toxigenic Vibrio cholerae in Bangladesh studied by numerical analysis of rRNA gene restriction patterns.

Authors:  S M Faruque; S K Roy; A R Alim; A K Siddique; M J Albert
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

7.  New variant of Vibrio cholerae O1 from clinical isolates in Amazonia.

Authors:  A Coelho; J R Andrade; A C Vicente; C A Salles
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  The emerging diversity of the electrophoretic types of Vibrio cholerae in the Western Hemisphere.

Authors:  G M Evins; D N Cameron; J G Wells; K D Greene; T Popovic; S Giono-Cerezo; I K Wachsmuth; R V Tauxe
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

9.  Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood.

Authors:  J T Weber; E D Mintz; R Cañizares; A Semiglia; I Gomez; R Sempértegui; A Dávila; K D Greene; N D Puhr; D N Cameron
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

10.  An accurate method for estimating sizes of small and large plasmids and DNA fragments by gel electrophoresis.

Authors:  P A Rochelle; J C Fry; M J Day; M J Bale
Journal:  J Gen Microbiol       Date:  1986-01
View more
  26 in total

1.  Pulsed-field gel electrophoresis-based molecular comparison of vibrio cholerae O1 isolates from domestic and imported cases of cholera in Japan.

Authors:  E Arakawa; T Murase; S Matsushita; T Shimada; S Yamai; T Ito; H Watanabe
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision.

Authors:  S L Chiang; J J Mekalanos
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Phenotypic and genotypic characteristics and epidemiological significance of ctx+ strains of Vibrio cholerae isolated from seafood in Malaysia.

Authors:  Chien-Hsien Chen; Toshio Shimada; Nasreldin Elhadi; Son Radu; Mitsuaki Nishibuchi
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

4.  Occurrence in Mexico, 1998-2008, of Vibrio cholerae CTX+ El Tor carrying an additional truncated CTX prophage.

Authors:  Munirul Alam; Shah Manzur Rashed; Shahnewaj Bin Mannan; Tarequl Islam; Marcial Leonardo Lizarraga-Partida; Gabriela Delgado; Rosario Morales-Espinosa; Jose Luis Mendez; Armando Navarro; Haruo Watanabe; Makoto Ohnishi; Nur A Hasan; Anwar Huq; R Bradley Sack; Rita R Colwell; Alejandro Cravioto
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

5.  Molecular evidence that a distinct Vibrio cholerae O1 biotype El Tor strain in Calcutta may have spread to the African continent.

Authors:  C Sharma; A Ghosh; A Dalsgaard; A Forslund; R K Ghosh; S K Bhattacharya; G B Nair
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh.

Authors:  Ana A Weil; Fahima Chowdhury; Ashraful I Khan; Daniel T Leung; Taher Uddin; Yasmin Ara Begum; Nirod Chandra Saha; Richelle C Charles; Regina C Larocque; Jason B Harris; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  Am J Trop Med Hyg       Date:  2012-09-10       Impact factor: 2.345

7.  Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in vibrio cholerae O1 strains isolated from 1979 to 1996.

Authors:  A Dalsgaard; A Forslund; N V Tam; D X Vinh; P D Cam
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Molecular analyses of Vibrio cholerae O1 clinical strains, including new nontoxigenic variants isolated in Mexico during the Cholera epidemic years between 1991 and 2000.

Authors:  Marcial Leonardo Lizárraga-Partida; Marie-Laure Quilici
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

9.  Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1.

Authors:  Ashraful I Khan; Fahima Chowdhury; Jason B Harris; Regina C Larocque; Abu S G Faruque; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Scand J Infect Dis       Date:  2010

10.  Molecular typing of Vibrio cholerae O1 isolates from Thailand by pulsed-field gel electrophoresis.

Authors:  Pramuan Tapchaisri; Mathukorn Na-Ubol; Watcharee Tiyasuttipan; Sansanee C Chaiyaroj; Shinji Yamasaki; Thitima Wongsaroj; Hideo Hayashi; G Balakrish Nair; Manas Chongsa-Nguan; Hisao Kurazono; Wanpen Chaicumpa
Journal:  J Health Popul Nutr       Date:  2008-03       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.